Description
MDMA Powder Crystals – Research Grade Analytical Standard | biosynlab
Product Details Table
| Specification | Details |
|---|---|
| Brand | biosynlab |
| Product Name | MDMA Powder Crystals (Research Grade) |
| CAS Number | 42542-10-9 |
| IUPAC Name | (RS)-1-(benzo[d][1,3]dioxol-5-yl)-N-methylpropan-2-amine |
| Molecular Formula | C₁₁H₁₅NO₂ |
| Molecular Weight | 193.24 g/mol |
| Purity | ≥99.5% (HPLC verified) |
| Appearance | White to off-white crystalline powder |
| Form | Crystalline solid / Powder |
| Storage | -20°C, desiccated, protected from light |
| Packaging | Amber glass vial with inert atmosphere seal |
| Intended Use | Analytical reference standard, forensic testing, research applications |
| Documentation | Certificate of Analysis (CoA), SDS, Batch records |
| Origin | EU-synthesized, GMP-compliant facility |
| Shipping | Temperature-controlled, compliant packaging |
SEO-Optimized Product Description
Introduction: Premium Research Standards for Advanced Scientific Applications
In the rapidly evolving landscape of psychopharmacological research, access to high-purity analytical standards has become paramount for laboratories, forensic institutions, and clinical research organizations worldwide. biosynlab, a leading European supplier of research-grade compounds, delivers pharmaceutical-grade MDMA powder crystals specifically synthesized for legitimate scientific inquiry and analytical calibration.
As regulatory frameworks surrounding 3,4-methylenedioxymethylamphetamine (MDMA) continue to shift—particularly with breakthrough designations for PTSD therapeutic applications—the demand for certified reference materials has surged across USA, European Union, and United Kingdom research markets. biosynlab addresses this critical need by providing rigorously tested, batch-consistent MDMA analytical standards that meet the stringent requirements of quantitative research, toxicological screening, and method validation protocols.
Industrial Applications & Research Context
biosynlab’s MDMA reference standards serve multiple high-value research verticals:
Forensic & Toxicological Analysis
Law enforcement agencies and toxicology laboratories require certified MDMA standards for HPLC-MS/MS method validation, seized substance quantification, and biological sample analysis. Our ≥99.5% purity specification ensures accurate calibration curves for quantitative determination in urine, blood, and tissue matrices.
Pharmaceutical Research & Development
With MDMA-assisted psychotherapy advancing through Phase III clinical trials (FDA Breakthrough Therapy designation), pharmaceutical manufacturers require GMP-compliant precursor and API reference standards for formulation development, stability testing, and impurity profiling.
Academic Neuroscience Research
University laboratories investigating serotonergic neurotransmission, entactogen pharmacology, and behavioral pharmacokinetics depend on consistent, high-integrity compounds for reproducible in-vitro and in-vivo studies.
Analytical Chemistry Method Development
Chromatography laboratories utilize biosynlab MDMA standards for developing and validating separation techniques including GC-MS, LC-MS/MS, NMR spectroscopy, and capillary electrophoresis protocols.
Manufacturing Excellence & Quality Assurance
biosynlab operates from state-of-the-art synthesis facilities across Germany, Netherlands, and Switzerland, employing proprietary synthetic methodologies that eliminate common contaminants including safrole derivatives, piperonyl impurities, and stereoisomeric variants.
Our cGMP-compliant production process includes:
- Multi-step purification achieving ≥99.5% chemical purity
- Chiral resolution capabilities for enantiomeric standard production
- Comprehensive batch testing via UHPLC-MS, qNMR, and elemental analysis
- Certificate of Analysis documentation with full traceability
- Stability studies supporting 24-month shelf life under recommended storage
Each production batch undergoes rigorous identity confirmation through ¹H-NMR, ¹³C-NMR, and mass spectrometry, ensuring structural integrity for quantitative applications.
Geographic Market Coverage
biosynlab maintains strategic distribution capabilities serving major research hubs:
United States Markets: Boston (biotech corridor), San Francisco (pharmaceutical R&D), Baltimore (NIH proximity), Seattle (emerging psychedelic research), New York (academic institutions)
European Union: Amsterdam (analytical chemistry), Berlin (pharmaceutical manufacturing), Barcelona (neuroscience research), Copenhagen (forensic standards), Zurich (pharmaceutical quality control)
United Kingdom: London (forensic services), Manchester (university research), Oxford/Cambridge (academic laboratories), Edinburgh (toxicology centers)
Responsible Research Framework
biosynlab exclusively supplies MDMA reference materials to verified research institutions, analytical laboratories, and licensed pharmaceutical developers. All transactions require:
- Institutional purchase orders
- DEA Schedule I research registration (USA) or equivalent national authorization
- End-use certification and compliance documentation
- Chain-of-custody protocols for controlled substance analogs
